Edition:
India

Shanghai Pharmaceuticals Holding Co Ltd (2607.HK)

2607.HK on Hong Kong Stock

20.15HKD
7:44am IST
Change (% chg)

HK$-0.05 (-0.25%)
Prev Close
HK$20.20
Open
HK$20.25
Day's High
HK$20.30
Day's Low
HK$20.05
Volume
226,300
Avg. Vol
3,752,487
52-wk High
HK$23.60
52-wk Low
HK$16.70

Latest Key Developments (Source: Significant Developments)

Shanghai Pharmaceuticals Holding unit receives GMP certificate
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS> ::* Says its wholly owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration .* Certificate issued pill and Chinese medicine extraction workshop of the unit and the valid period is until Nov. 30, 2022.  Full Article

Shanghai Pharmaceuticals Holding unit receives GMP certificate
Tuesday, 5 Dec 2017 

Dec 5(Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS> : :Says its Shanghai-based unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration.Says the valid period is until Nov. 27, 2022.  Full Article

Shanghai Pharmaceuticals Holding unit receives GMP certificate
Sunday, 3 Dec 2017 

Dec 3(Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>:Says its wholly owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration.Says the valid period is until Nov. 21, 2022.  Full Article

Cardinal Health to sell its china business to Shanghai Pharma for $1.2 bln‍​
Wednesday, 15 Nov 2017 

Nov 14 (Reuters) - Cardinal Health Inc -:Cardinal health signs definitive agreement to sell its china business to Shanghai Pharma.Deal for $1.2 bln‍​.‍Does not include Cardinal's remaining businesses in China, including Cordis, its medical sourcing team.‍Sale includes Cardinal Health's pharmaceutical and medical products distribution business in China​.‍Eric Zwisler, chairman of Cardinal Health China, will retire effective immediately as part of sale​.  Full Article

Shanghai Pharmaceuticals' unit‍ signs deal to acquire Cardinal in Malaysia
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>:Says its unit‍ Century Global signs deal to acquire Cardinal Malaysia for about $557 million.  Full Article

Shanghai Pharmaceuticals Holding Co ‍says unit to buy Cardinal Malaysia for US$557 mln
Wednesday, 15 Nov 2017 

Nov 14 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>:‍Century Global to buy Cardinal Malaysia from Cardinal Cayman for US$557 million.  Full Article

Shanghai Pharmaceuticals Holding unit receives GMP certificate
Monday, 13 Nov 2017 

Nov 13(Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>:Says co's Shanghai-based pharmaceutical unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration recently, for a kind of bulk drug, with valid period until Sept. 7, 2022.  Full Article

Shanghai Pharmaceuticals Holding unit receives GMP certificate
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS> ::Says its unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration recently .  Full Article

Shanghai Pharmaceuticals Holding unit receives GMP certificate
Monday, 6 Nov 2017 

Nov 6(Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS>:Says its unit received goods manufacture practice (GMP) certificate from Zhejiang Food and Drug Administration, for small capacity injection .Says the valid period is until Sept. 20, 2022.  Full Article

Shanghai Pharmaceuticals Holding unit receives GMP certificate
Friday, 3 Nov 2017 

Nov 3 (Reuters) - Shanghai Pharmaceuticals Holding Co Ltd <601607.SS> ::* Says its unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration .* Certificate issued pyridostigmine bromide API manufactured by the unit and the valid period is until Sep. 28, 2022.  Full Article

BRIEF-Shanghai Pharmaceuticals Holding unit receives GMP certificate

* Says its wholly owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration